title: [Irritable bowel syndrome: the next-to-last that is being investigated].
authors.affiliation: Consulta de Trastornos Funcionales Digestivos, Servicio de Aparato Digestivo, Hospital Royo Villanova, Zaragoza, España. Electronic address: jjsebastian@salud.aragon.es.
authors.forename: Juan J
authors.initials: JJ
authors.lastname: Sebastián Domingo
mesh_terms: D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D015415:Biomarkers; D000529:Complementary Therapies; D004032:Diet / Q000009:adverse effects; D004040:Dietary Carbohydrates / Q000009:adverse effects; D000069467:Fecal Microbiota Transplantation; D005285:Fermentation; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000209:etiology / Q000276:immunology / Q000378:metabolism / Q000628:therapy; D008550:Melatonin / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use; D019936:Probiotics / Q000627:therapeutic use
chemical_list: D000929:Antidepressive Agents, Tricyclic; D015415:Biomarkers; D004040:Dietary Carbohydrates; D010455:Peptides; D008550:Melatonin; C523483:linaclotide